This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Estia Health Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Estia Health hat ein Gesamteigenkapital von A$500.6M und eine Gesamtverschuldung von A$70.0M, was einen Verschuldungsgrad von 14% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen A$1.9B bzw. A$1.4B.

Wichtige Informationen

14.0%

Verhältnis von Schulden zu Eigenkapital

AU$70.00m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	AU$26.69m
Eigenkapital	AU$500.56m
Gesamtverbindlichkeiten	AU$1.37b
Gesamtvermögen	AU$1.87b

Jüngste Berichte zur Finanzlage

Recent updates

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Feb 25

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Nov 04

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Apr 13

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Mar 08

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Feb 21

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Jan 24

Is Estia Health (ASX:EHE) Using Too Much Debt?

Dec 29

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

Dec 08

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Jul 26

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Jul 07

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: EHEDie kurzfristigen Aktiva des Unternehmens (A$60.6M) decken seine kurzfristigen Passiva (A$1.2B) nicht.

Langfristige Verbindlichkeiten: EHEDie kurzfristigen Vermögenswerte des Unternehmens (A$60.6M) decken seine langfristigen Verbindlichkeiten (A$195.1M) nicht.

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: EHEDie Nettoverschuldung im Verhältnis zum Eigenkapital (8.7%) wird als zufriedenstellend angesehen.

Schulden abbauen: EHEDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 10% auf 14% gestiegen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: Obwohl EHE unrentabel ist, verfügt es über eine ausreichende Cash-Runway für mehr als 3 Jahre, wenn es seinen derzeitigen positiven freier Cashflow beibehält.

Vorhersage Cash Runway: EHE ist unrentabel, verfügt aber über eine ausreichende Liquiditätsreserve für mehr als drei Jahre, selbst wenn der freie Cashflow positiv ist und um 4.9% pro Jahr schrumpft.

This company listing is no longer active

Estia Health Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Is Estia Health (ASX:EHE) Using Too Much Debt?

Recent updates

Estia Health Limited Announces Cessation of Helen Kurincic as Director

Consensus EPS estimates fall by 30%, revenue upgraded

New minor risk - Dividend sustainability

Estia Health Limited Announces Dividend, Payable on September 15, 2023

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 16%

Estia Health Limited (ASX:EHE) entered into a binding agreement to acquire residential aged care homes in Benalla of Royal Freemasons Ltd.

Estia Health Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Bain Capital Reportedly Moves to Sell Craigcare But Abandons Its Pursuit of Estia

Consensus EPS estimates fall by 15%

Price target increased by 12% to AU$2.83

Independent Non-Executive Chairman recently bought AU$52k worth of stock

Consensus EPS estimates fall by 22%, revenue upgraded

First half 2023 earnings released: AU$0.098 loss per share (vs AU$0.031 loss in 1H 2022)

Estia Health Limited to Report First Half, 2023 Results on Feb 21, 2023

CEO, MD & Director recently bought AU$106k worth of stock

Consensus forecasts updated

Estia Health Limited Announces Retirement of Mr. Steve Lemlin, Chief Financial Officer

Consensus estimates of losses per share improve by 51%

Estia Health Limited, Annual General Meeting, Nov 03, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Estia Health Limited Announces Appointment of Simon Willcock as Non-Executive Director Effective 1 September 2022

Estia Health Limited Appoints Sean Bilton as Director

Estia Health Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Consensus forecasts updated

Insufficient new directors

Estia Health Limited Announces Management Changes

Estia Health Limited announces resignation of Hon. Warwick L. Smith AO as director, effective 31 March 2022

Consensus forecasts updated

Estia Health (ASX:EHE) Takes On Some Risk With Its Use Of Debt

First half 2022 earnings: EPS misses analyst expectations

Estia Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Consensus forecasts updated

Here's Why We Think Estia Health Limited's (ASX:EHE) CEO Compensation Looks Fair

Insufficient new directors

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.45 loss in FY 2020)

Estia Health (ASX:EHE) Use Of Debt Could Be Considered Risky

Price target increased to AU$2.15

Has Estia Health (ASX:EHE) Got What It Takes To Become A Multi-Bagger?

Price target raised to AU$1.94

First half 2021 earnings released: AU$0.02 loss per share (vs AU$0.055 profit in 1H 2020)

Estia Health Limited Not Declare Interim Dividend for the Six Months Ended December 31, 2020

What You Need To Know About Estia Health Limited's (ASX:EHE) Investor Composition

Estia Health Limited Reaches an Agreement to Settle the Shareholder Class Action Commenced Against It in July 2019

New 90-day high: AU$1.96

If You Had Bought Estia Health's (ASX:EHE) Shares Five Years Ago You Would Be Down 73%

Is Estia Health (ASX:EHE) Using Too Much Debt?

Estia Health Limited to Report Q2, 2021 Results on Feb 23, 2021

Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares?

New 90-day high: AU$1.63

New 90-day low: AU$1.36

New 90-day low: AU$1.37

Non-Executive Director recently bought AU$101k worth of stock

Price target lowered to AU$1.62

Earnings released

Estia Health Limited Determines Not to Declare A Final Dividend for Fiscal Year 2020

Did Estia Health Limited (ASX:EHE) Insiders Buy Up More Shares?

Is There Now An Opportunity In Estia Health Limited (ASX:EHE)?

Estia Health Limited(ASX:EHE) dropped from S&P/ASX 200 Index

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen